Cerenome is trading 6.22% down at $1.81 as of 10:41 a.m. ET on October 12, 2026, with the specific driver unclear.

  • Molecular profile tests became available to order on October 12; their launch was announced October 6, so it is not a new catalyst clearly linked to the drop.
  • Broader markets were nearly flat, rather than sharply lower, and the available evidence does not establish a market-wide explanation.